These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 31612653)

  • 21. Serum calcium, magnesium, phosphorus, and vitamin D in benign essential blepharospasm.
    Serefoglu Cabuk K; Tunc U; Ozturk Karabulut G; Fazil K; Karaagac Gunaydin Z; Asik Nacaroglu S; Taskapili M
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1293-1297. PubMed ID: 32236706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm.
    Lai KKH; Tsang A; Kuk AKT; Ko CKL; Chan E; Ko STC
    Neuroophthalmology; 2021; 45(5):293-300. PubMed ID: 34566211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A-30 Years of Experience in a Tertiary Care Center.
    Wabbels B; Fimmers R; Roggenkämper P
    Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections.
    Yabumoto C; Osaki MH; Osaki T; Gameiro GR; Campos M; Osaki TH
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):475-478. PubMed ID: 36928309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease.
    Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY
    Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health-related quality of life of daily-life-affected benign essential blepharospasm: Multi-center observational study.
    Hirunwiwatkul P; Supawatjariyakul W; Jariyakosol S; Apinyawasisuk S; Sriratanaban J; Chongpison Y; Jagota P; Aui-Aree N; Witthayaweerasak J; Setthawatcharawanich S; Kitthaweesin K; Chirapapaisan N; Chaimongkoltrakul P; Laowanapiban P; Hansapinyo L; Panpitpat S; Kurathong S; Nimworaphan J; Thitiwichienlert S; Vanikieti K; Samipak N; Srimanan W; Mekhasingharak N; Chaitanuwong P
    PLoS One; 2023; 18(3):e0283111. PubMed ID: 36920965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visual evoked potential changes following Botox administration in patients with blepharospasm.
    Eski MT; Teberik K; Sezer T; Ayasli AH; Ozturk A
    Int Ophthalmol; 2023 Jun; 43(6):2101-2107. PubMed ID: 36652021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Re: "Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections".
    Gokharu S; Rehman O; Das S
    Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):357-358. PubMed ID: 38738715
    [No Abstract]   [Full Text] [Related]  

  • 29. Reply Re: "Ocular Surface Metrics in Blepharospasm Patients After Treatment With Botulinum Toxin Injections".
    Osaki TH; Yabumoto C; Osaki T; Osaki MH
    Ophthalmic Plast Reconstr Surg; 2024 May-Jun 01; 40(3):358. PubMed ID: 38738716
    [No Abstract]   [Full Text] [Related]  

  • 30. Quantitative assessment of botulinum toxin injection on blink rate in blepharospasm.
    Yazdanpanah G; Yen MT; Pflugfelder SC
    Orbit; 2023 Dec; 42(6):571-578. PubMed ID: 36484152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported outcomes following a break in ophthalmic botulinum toxin therapy during the COVID-19 pandemic.
    Jamison A; Favor M; Malhotra R
    Can J Ophthalmol; 2024 Feb; 59(1):e41-e45. PubMed ID: 36372133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Two Botulinum Neurotoxin A Injection Patterns with or without the Medial Lower Eyelid in the Treatment of Blepharospasm.
    Yang H; Lu J; Zhao X; Ding X; Wang Z; Cai X; Luo Y; Lu L
    J Ophthalmol; 2016; 2016():5957812. PubMed ID: 26885381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin for benign essential blepharospasm: A systematic review and an algorithmic approach.
    Rayess YA; Awaida CJ; Jabbour SF; Ballan AS; Sleilati FH; Abou Zeid SM; Nasr MW
    Rev Neurol (Paris); 2021; 177(1-2):107-114. PubMed ID: 32654779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of strabismus and blepharospasm with Botox (onabotulinumtoxinA): Development, insights, and impact.
    Scott AB; Fahn S; Brin MF
    Medicine (Baltimore); 2023 Jul; 102(S1):e32374. PubMed ID: 37499080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Micro Botulinum Toxin for a Face-lifting Effect: A Systematic Review.
    Ng ZY; Lellouch AG
    Dermatol Surg; 2022 Aug; 48(8):849-854. PubMed ID: 35560135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Repetitive Transcranial Magnetic Stimulation Combined with Botulinum Toxin Type A for Benign Essential Blepharospasm Patients Accompanied by Anxiety and Depression.
    Yin B; Peng B; Luo Y; Fan S; Xiao T; Zou X; Dong H
    Neuropsychiatr Dis Treat; 2021; 17():2707-2711. PubMed ID: 34429606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensory Trick Frames: A New Device for Blepharospasm Patients.
    Lorenzano D; Tansley S; Ezra DG
    J Mov Disord; 2019 Jan; 12(1):22-26. PubMed ID: 30642155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Exploratory, Randomized, Double-Blind Clinical Trial of Dipraglurant for Blepharospasm.
    Kilic-Berkmen G; Kim H; Chen D; Yeo CI; Dinasarapu AR; Scorr LM; Yeo WH; Peterson DA; Williams H; Ruby A; Mills R; Jinnah HA
    Mov Disord; 2024 Apr; 39(4):738-745. PubMed ID: 38310362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm - A Randomized Pilot Study.
    Silkiss RZ; Koppinger J; Truong T; Gibson D; Tyler C
    Transl Vis Sci Technol; 2023 Aug; 12(8):17. PubMed ID: 37606606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible role of frankincense in the treatment of benign essential blepharospasm.
    Baker MJ; Harrison AR; Lee MS
    Am J Ophthalmol Case Rep; 2023 Jun; 30():101848. PubMed ID: 37252049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.